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ABSTRACT 
In view of the success of the Danish investigators Christensen 
and Kj.ems in inducing regressions of malignant tumors with strap-
tocoocus bacteriophage lysates~ it was decided to test lysates of 
hemolytic Staphylococcus aureus upon malignancies in h8ll1Sters and. 
mice. 
Experimental An~als 
1. BALB/c albino mice. 
2. The golden hamster (Mesocrioetua auratus). 
Neoplasms 
1. Lymphoid leukemia induced in the BAtB/o mice With the 
Moloney lymphoid leukemia virus. 
2. A spindle-cell sarcoma. of the hamster induced by intra-
muscular injection of methyloholanthrene in 1950, and now in its 
89th passage. 
Bacteriophage Lysates 
Standardized bacterial preparations designated as "Bacterial 
~ 
.Antigen Staphage Lysates (Staphylococcus aureus, Serologic Types r: 
and III" obtained from Delmont Laboratories, Swarthmore, Pennsyl-
vania. 
Experiment I 
Two groups of mice were used. One was injected With leukemia 
Virus at birth, and treatment With lysate was not begun until 
0 
0 
after leukemic symptoms had developed. The other group was started 
on injections of lysate before being inoculated with leukemia. 
Control animals re~eived injections of 0.9% saline. Injections were 
intraperitoneal; dose begun at 1/8 co. and increased in incrementa 
of 1/8 cc. until _the 1/2 ec. level. The t.ype III lysate was used. 
In neither group was the course of the disease appreciably altered 
from that of the controls by the lysate therapy. 
Experiment II 
Sixty h~ters were divided into 3 groups of 20 animals each. 
Group A was treated with lysate Type I, Group B with lysate Type III, 
and Group C (control) received sterile beef heart infusion broth. 
Injections were given subcutaneously between the scapulae 3 times· 
a week and were started the day before the sarcoma was transplanted 
into the animals. The dose was 1/2 co. in all cases. The trans-
plants were made into the right cheek pouch with a 15-gauge trochar. 
In Group A, 4 tumors (2Q%) regressed. In Group B, 1 tumor (5%) 
regressed and 3 showed markedly retarded growth. In Group c, 1 
tumor regressed and 1 shovred retarded growth. A chi square test of 
the regressions in Group A against the controls gave a probability 
of between 10% and 25% that the groups were the same. 
Histological study ~f the regressing tumors showed vascularity 
to be poor or lacking. Mitoses were rare and the tumors were in-
filtrated with polymorphonuclear leukocytes. 
After excision of the primary transplants, the animals remaining 
alive in each group were given a second transplant of sarcoma into 
0 
:x:i. 
the other cheek pouch. 36% of the Group B animals proved resistant to 
the second transplant as compared to 9% in Group A and 14% in Group Be 
A chi square test of the number of regressions in Group B as compared 
with the controls gave a probability level of less than 5%. 
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l. 
t • Introduction 
A· Historical Background 
With the emergence of bacteriology as a science late in the 
-
last century, the interest of many workers turned' to the possibility 
that microorga~isms might in some way be eonnected with malignant 
disease. Some believed that microorganisms ware the actual cause of 
cancer(l,2); others that microorganisms or their products might b~ 
utilized as therapeutic agents in the control of malignancy~3 ) •. 
Recent advances in antibiotic therapy( 4 ) have renewed hope 
that a biochemical ~gent associated with bacteria may be discove~ed 
which will :e~ert a destructive effect upon neoplastic growt;h without 
seriously interfering with normal cells. 
The work relative to microorganisms and tumors has had a 
largely empirical b§aisa Nauts(3), in his review of the effects of 
bacterial products and infections on malignant tumors, points out that 
for over 200 years reports have been made of the regression of neo-
plasma following acute ~nfictions. If the cancers were not too far 
advanced and the infections ware severe, the tumors disappeared and 
did not recur; whereas if the infection was mild and the malignancy 
extensive, only temporary regressions occurred. The infection most 
t,commonly involved in these recoveries was erysipelas. 
The first attempts at the treatment of malignancy based upon these 
reports ware initiated by Busch(5) in 1868. He endeavored to produce 
erysipelas in his cancer patients,but was unsuccessful in inducing 
0 the infection because he was unaware of its streptococcal origin. Fehliesen(3 )~ after his discovery of the organism responsible for 
erysipelas in 1882, injected live cultures of the streptococci into 
,, 
2. 
cancer patients and obtained "encouraging results". Since then, many 
microorganisms and their products have been reported to have soma 
therapeutic value in the treatment of malignancy. Xhesa have included 
Serratia marcescens and gonococci, certain spirochaetes, Clostridium 
histolyticum, Bacillus subtilis, Bacillus coli, Staphylococcus aureus 
ana' Klebsiella pnaumoniae(6). 
Colay( 7), following Fehliesan's discovery of the causal agent of 
erysipelas, began treating cancer patients1 by direct injection of broth 
cultures of streptococci into the tumor. His cultures were obtained 
from erysipelas patients. He induced shrinking of the tumors by this 
method, but complete regression was obtained only in those patients 
who developed a systemic erysipelas infection. Sarcoma responded to 
the treatment more readily than carcinoma in a ratio of about 3:1. 
However, many patients proved immune to the infection; in soma 
o~hars the infection was fatal. Cultures of erysipelas sterilized by 
heating or formalin were weak and ineffective. 
Coley(8) assumed cancer was caused by a microorganism and felt it 
11quite easy to understand that the toxic products of the erysipelas 
' 
streptococci might being about such changes in the blood serum as to 
destroy the parasite of cancer or inhibit the growth~. H6 believed 
. 
that the toxic products could be isolated and used without producing 
erysipelas. 
Col~y spent the remainder of his life developing a series of 
preparations for the trea~ent of cancer. He learned of the work of 
Roger< 9) with !• marcescens (llac~l'lus. prodigiosus) which showed that the 
p~esence of this organism or its toxins frequently increases the 
virulence of associated organisms. Coley tried mixing the toxins of 
0 
0 
~S: mar~escens with those of erysipela•• The resulting product· showed 
same success with certain sarcomas but was not potent enough to cure more 
resistant types of malignancy. 
Ooley developed more than 15 formulas for his 11Coley' s Mixed 
"' - ~ . 
ToxinlJ.", all but 4 of which- aocording to Nib:Gi>i(...op.cit· .. )dwei'..e ..... wsak··a'J:id, $iable. 
. . . 
The toxins were used on a small scale in hospitals and private practice 
. . . 
in this country and abroad _over a period of about _60 yeara_, but the 
resulta are difficult to evaluate. Al standard bioassay to insure a 
_. '0" •v ,. 
definite potency of the products vtas not used, the techniques of treat• . 
. . . 
m~nt ~ried Widely,_ an~ no_ standard ~ethod of r!cordin~ technique~ re-
actions elicited and results ware employed. Nauta, however, after a 
... .. .. . .. .. 
careful study ~f 12~ ca~~s treated with the vari~us Coley toxins, con-
cludes that 11Toxin therapy (when reasonably potent products are admin-
- • , '1. ... .. .. 
istered With a p~o~~r ~echn~q~e)_caus~~ destruction of tumor tissue and 
apparent immunity to further recurrence or metastases''. He points out 
.. -'"' .,... .. 
that the pre~~ra~i~n~ ~ar~ ~~t ~ore_Y_~ide~y us~d. because the "existi~ 
s~ro~ evidenc~ w~a .~c~~~?=~~ ~d-~a~ n!~r bee~ presen~e~ in such a man-
ner as to allow toxin therapy to ~om~~~~ wit~ its more popular competi-
.. ~ - . - .. ... .. . 
tors~ the X-r~_ma~hi~~,_radium, or some of the recently discovered 
chemotherapeutic age~ta"• 
Beebe and TracyQ9 ) reported 11ra~id and complete r~cover,r ot all 
tumors" after treatm~nt of lymphosarcoma in dogs with toxins from 
streptococci and-~· p;-od~~~~W!.· They. also triad filtrates of Sta.R-.~­
looocous_~ganes var.~~~u.~ but reported only localized necrosi• 
at the site of injection of the filtrates into the tumor • 
...- ..... ... .... .. ·- ... . "'( .. ,.. .. .. . ......... .. .. .... ~ - ...... -- " 
• 10 
Oomsia' 1 noted arrested development of grafts of Ehrlich tumor 
0 
0 
in mice which had contracted a recurrent spirochaetal infection. 
The tumors became granular, enc~usted and ne~rotic. Further study 
shewed a reciprocal relationship: canc~~o~s animals were less sus-
ceptible t~~~~-fever and infected animals were n~t as susceptible to 
the tranaplantu. 
. ·-
In 1928 Shwartzman(ll) discovered that a subcutaneous injection of 
bacterial filtrate into a rabbit or guinea pig, followed in 24 hours 
by an intravenous i~ject~cn of the same fi~trate, resulted iu a severe 
hemorrhagic necrotic reac~ion_at t~e site of the ?riginal injection. 
irork of Gratia and Linz<~~}.witb the ·S~zman·~hename~~nshowad 
that the hemorrhagic lesions were not restricted to the skin but c~uld 
also be induced in lymph nodes, thymus, lung, and kidneys. On thil 
. . 
basis these authors decided to see if necrosis could be induced in 
. . 
They used a liposarcoma and were 
. . 
successful in induoin~ the_n~o~~ti~_reaotion in guinea pi~a bearing this 
tumor, without causing hemorrhage in the nor.mal tissues. They later 
« ... -.. .. .. .. .. "'. w 
found that the reactions co~~ also be ~roduced ~thout the initial 
preparatory injeot~o~ ~ th~_gu~n~a.I?igs"had l:tad a bacterial infection 
such as le charbon, or an involvement with a virus such as vaccinia • 
.. - .... .., .. 
~ 
This seemed to'them to indicate that the infection had caused the 
necessary "~rep~~tion" of the tissues. 
Viral etiology of malignant proliferation had been suggested b,y 
.. ... ""' .. .. 
~ worke:s, ~nd Gratia a~d Linz~felt that if this ware a fact the 
tissues ~ight ~lr~ad~ be ~1prel?ared11 b;'[ .. the. causative virus and that the 
intravenous do~~. ~l~~e. would .. suf_fi~e -~ o produce necrosis of the tumor • 
Their further studies with guinea pigs tended to bear this out, 
0 
0 
5. 
although sufficient animals were not employed to draw any definite con-
elusions. 
Shwartzman and .Michailovsq(l3 ) also succeeded in produoin~· ths Shwartzman 
. 
reaction without prior prepara~or,y injection# using meningococcua 
filtrate in mice bearing sarcoma 180. 
Duran-Reynals(l4) exbended the work of Gratia and Linz. He used 
tumor-bearing e~_er~ental __ animals whiah are normally resistant to the 
Shwartzman phenomen~n_(rata and mice)_~~d .injected ~hem intraperiton• 
eally with filtrates of_~ ~ S~ow-~rowing and non-malignant tumors 
sh~ed negative results# b?t r~pi?~~ _groWing_malignant tumors such as 
Walker• s sarcoma and M/63 adeno-carcinoma proved nearly 100% susceptible 
. .. . .. .. ... . ... .. 
to the hemorrhag~c reaction. He, too, found that no previous local 
injection with the filtrates was naoessar.y to elicit the reaction as 
would have been necessar,Y with the ordinar,y Shwartzman reaction in 
rabbits and ~uinaa pigs._ ~he gen~ral resistance of the rats and 
mice to the ordil'!-9:ry Shw~!tz:man reaction was not oh~nt;ed by the existm. ce 
of the tumor. Duran-Reynals felt that special conditions must exist 
- - ,.. ... 
in the tumor to cause its blood vessels to react with the blood-
carried bacterial toxins. 
Further work by J?uran-~eyn~ls ~ lQ) with both SJ?Ontaneous and1 trans-
planted t~rs l~~d_him.to ~~ conolus~?n that the degree o~ pre-existing 
necrosis ~nth~ tumor ~sa go?d in~e~ of_~e ~~~rae of tumor suscept-
ibili~, neoro~is ~e;~ a.~P~~ial ~~a~~ ~f Tasoular fragility which 
render; the rapidly growing tumor vulnerable to the injected toxin, 
.. ,.._ ........ -~~ -~·... ~"' 
evan if the latter is practically har.mless for the normal animal. 
0 
0 
6. 
The work of Algire(lS), described in the following paragraphs, clarifies 
sommvha~· the nature of the tissue reactions involved in the studies above. 
Ee has observed vascularization in both normal and tumor tissue using the 
transparent chamber technique. He finds tPat during vascularization of 
mammary carcinoma and sarcoma the tumor vessles, though retaining their 
capillary structure, are sinusoidal in navure and average about 8 t~es 
the diameter of adjacent capillaries between the .muscle fibers. Vascu• 
larity in the surrounding connective tissue is about'25% of the total 
tissue volume·, as compared to about 55% in the tumor tissue. "Vascularity" 
. 
or "vascular level" as defined by Algire is the percentage of the volume 
of tissue ~easured which consists of .t'unctional.,;vessels. This is obtamed 
by a method of sampling based on geometric probability which is described 
in detail in his paper. 
·upon injection of the bacterial polysaccharide from !!prodigiosus into 
the peripheral vascular bed of non-tumor bearing an~ls Algire noted a 
rise of vascular level from 25% to 35%, which was caused by a dilatation of 
the arterioles and venules. Associated With this dilatation was an inoreas-
ingly sluggish blood flow and 11a remarkable increase in leukocytes in the 
. 
circulating blood"• No hemorrhaging was observed. By the next day the 
~ 
vascular level had returned to the usual base line of 25%. 
WhenAlgire injected the bacterial polysaccharide into tumor tissue, 
however, there was no sign of vasodilation. Vascular level dropped 
steadily and by the end of 4 hours had fallen from 55% to 24%. Numerous 
petechial hemorrhages developed and gross fluid and red blood cells 
surrounded the tumor. Functional vascular laval had dropped to zero at 
the end of 4 hours. By the end of the 4th day, the tumor had become 
entirely necrotic, apparently due to loss of vascular supply, but by 
the 5th day new capillary sprouts became visible about the peripher.y and 
tumor growth again commenced. 
0 
0 
7. 
The phenomena described by Algire, as he states
1
, "do not rule out 
the possibility of a direct lethal action of the polysaccharide on the 
tumor cell, but an adequate explanation of such lethal action would 
have to explain the vascular phenomena described". 
Connell(l?) used a slightly different approach. He grew ~histo­
lyticus on scirrhous breast carcinoma suspended in physiological saline 
in an attempt to stimulate production of enzymes specific for proteo-
lysis of the cancer tissue. He used filtrates of the tumor - bacillus 
culture in the treatment of human can?ers and reported "arrest" and 
"softening" of the tumors and marked symptomatic relief, but no cures. 
Jacobi(lB), using a diluted filtrate of!:_ typhosus, produced the 
necrotic reaction of Shwartzman in 2 kinds of rat carcinoma and the 
Rous chicken sarcoma. This was followed by sloughi~g of the tumors, 
after which only a few recurrences ware noted. 
Zahl ~ al. (19) reported that with few exceptions killed gram. net;ati va 
bacteria induce capillary hemorrhage in implanted mouse tumors. However, 
he found that this property is almost entirely lacking in gram positive 
forms. In larger doses their preparations were toxic to normal vascular 
tissue. The authors feel that the ~marcescens (gram-negative) com-
ponent of Coley's toxins operates as a vascular poison to the tumor 
capillary bed. The streptococcal components are nonhemorrhagic and therefore 
must exert their effect upon the tumors through another mechaniS<m• 
Jacobsen< 20) points out the lessened frequency of neoplastic disease 
in patients with active tuberculosis, chronic osteomyelitis, and acute 
infectious disease in general. He cites the increasing incidence of 
cancer in the 30..50 age group and concludes that: 
1. The reticulo-endothelial system When sufficiently 
activated by acute infectious processes, ·may 
attain the ability to cope With neoplastic disease. 
2. The present increase in malignant morbidity is 
due to the decreased resistive powers of the 
reticulo-endothelial system resulting fro.m lessened 
exposure to the infectious diseases 'Which were 
prevalent before the advent of modern puolic health. 
a. 
Jacobsen's conclusions are based largely on statistical surveys-
however, and his correlations have since been questioned( 2l). 
Shear (22,23) produced some symptomatic relief by administering 
s. marcescens polysaccharides to patients ~th inoperable cancer. 
Post-mortems showed gross changes in tumor size and consistency as well 
as microscopic evidence of necrosis and hemorrhage in both animal and 
human tumors. Shear concludes, however, that immunity reactions, 
differential tissue resistance and a toxemia resulting from necrosis 
tend to weaken the rationale for use of hemorrhagic bacterial materials. 
He refers to the effects caused by the bacterial polysacCharides as 
"laboratory curiosities", whose mechanism of action is still obscure. 
~ ~ 
Shear agrees with Jacobsen that there is indeed an increase in the 
incidence of malignant diseases, even When figures are corrected 
for improved methods of diagnosis and £or age distribution, and that 
there is a concurrent, and possibly related, decline in infectious 
disease. Shear cites the survey done at Children's Hospital in Boston 
Where it was found that 3/4 of the spontaneous re~issions of leukemia 
occurred following an episode of acute infection. 
As in the other forms of malignancy, beneficial effects of acute 
concurrent infections or fever on leukemia have long been reported in 
0 
0 
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the literature. Palner at !!·(24:1) cites 70 oases in which remission 
of leukemic sympto~ occurr~d duri~g or following such infections as 
typhoid, malaria, miliar,y tuberoulo~is, staphylococcus pneumonia, in-
fluenza and empyema. ~e~is~ions have also been reported following 
administration o~ Cole~~~ toxins and t~erculin. Pelner feels the 
observations of such investigators as Southam( 2R) 'and Ungar(2a) suggest 
- " . 
that the reticulo-endo~he~ia~. ~ys-~em of ~~?ar_~atiants is less active 
than normal, the ability to invoke the inflammatory reaction baing 
- . .... .. -... - -
absent in most patian~~~- _Su~h. _st~ul~ as toxin or concurrent infec-
tions may be able temporarily to stimulate the retioulo-andothe]ial 
sysi;em. 
Wintroba(21-), however, after a critical review of the literature 
and his awn observation of a series of 86 consecutive cases of human 
. . . 
leukemia, feels t~at t~ere is li~~le evidence to support the thesis 
that a remiss~on ~~.le~emic s~ptom~ fr~~uently oc~urs in association 
with an intercurrent infection. He states:- "The occurrence of a 
remission in association with infection in chronic laukemia •••• cannot 
be denied. ~~ve:! ~-~emission is probably a vary unusual event 
rather than a common one." 
Jordan!!!, .!!J2.S) report massive degeneration and necrosis of tumor 
tissue when a localized streptococcal adenitis ~s superimposed upon 
a localized lymphoma pr~duoed by intranasal deposition of ascitea-for.m 
leukemia calls in AKR m~ce. The authors feel that the streptococci 
. 
exert a direct cytopathogenic affect on·the tumor cells. 
10. 
In 1951 a Boston physician gained considerable unofficial publicity 
by using a hemolytic Staphylococcus aureus phage lysate in the treat-
ment of cancer and allied diseases. The Massachusetts Medical Society 
published a report(29) ~n this therapy which concluded that: 
•••• no proof has been presented nor was any 
able to be obtained which has shown that 
beneficial organic changes have occurred in 
disease processes treated by that therapy 
which have been due to that therapy and to 
that alone. 
On this basis the Society did not recommend that any animal ex-
periments be done or any hospital study of the tre~tment be made. Aa 
far as can be discerned by a search of the literature since the Massachu-
setts Medical Society's Eeport, no animal experiments have been published 
involving the use of staphylococcus phage-lysates to treat tumors. 
In 1959 Christensen<30) endeavored to confirm the old hypothesis 
of antagonism between malignant tumors and infectious disease. Accord-
ingly he subjected rabbits with Brown-Pearce carcinoma to repeated 
massive infections by hemolytic streptococci. Although the primary tumors 
I 
remained unaffected, there was less occurrence of metastases among the 
infected animals than runong the controls. Similar results were obtained 
by treating the rabbits with phage-lysed hemolytic streptococci. 
Experiments with heat-killed or formalin-killed streptococci, endotoxins 
or exotoxins were negative. 
The infections resulted in a high mortality runong the rabbits. 
whereas the lysates proved non-toxic. Since by using lysates the authors 
found that metastases could be inhibited without the general condition 
of the animals suffering in any way during treatment, further experiment-
0 
0 
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ation along this line was undertaken by Christensen and Kj~s(3l). 
' 
Three different lysates of hemolytic streptococci were used. All three 
proved capable of inhibiting the growth of tumors in a large number of 
rabbits. Out of 126 lysate-trea te·d rabbits, 29 had metastases. Out 
of 113 placebo-treated, 110 had metastases, and all 71 untreated rabbits 
had metastases. In 44 out of 126 lysate-treated rabbits (35%~ no 
< 
viable tumor tissue was evident macroscopically at autopsy, whereas 
all placebo-treated and all untreated rabbits had moderate or large 
quantities of~tumor tissue at autopsy. 
Be Statement of .Purpose 
In view of the success of the Danish investigators Christensen and 
Kjems with streptococcus phage lysates and the renevred interest of 
many investiga·uors in questions of ·immunity and cancer, it was thought 
that an interesting project would be one in which lysates of hemolytic 
Staphylococcus aureus were tested upon malignancies in hamsters and 
mica. 
A pilot study using a small number of hamsters yielded a 
sufficient number of tumor regressions to make a large·r study seem 
warranted. 
It was decided to test the effect of the hemolyt:ic Staphylococcus 
aureus lysates on an induced hamster tumor (available at Boston 
University1 and on a virally caused mouse leukemia. 
0 
MATERIALS 
AND 
METHODS 
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Ir •. Materi~la and Methods 
A• Experimental Animala 
1. Mice 
Dr. J. B. Moloney of the National Cancer Institute, Bethesda, 
Maryland, kindly supplied both laukemio and normal mice for this exper-
iment. Twenty-six BALB/c albino mice were received from him. Twelve 
were 42-day•old normal mice. The other 14 were 100 days old and 
had been inoculated the day after birth with cell~free extracts of 
lymphocytic neoplasms. 
2. Hamsters 
Sixty golden hamsters (Mesocricetus auratus) of both sexes 
-
were obtained from the Bioresearch Laboratories, Orumbridge, Massachusetts. 
Their average weight was 80 grams. 
The hamster was chosen as an experimental animal because: 
a. The richly vascular blind end of the cheek pouch affords 
a transplantation site which can be viewed as frequently as desired 
without injury to the animal. 
b. The use of aseptic technique has been found by e~er­
ience not to.be of any special benefit~32 ) 
c. The tumor chosen for these experiments has been shown 
to yield nearly 100 per cent takes in the hamster(33). 
B~ Neoplasms 
1. Lymphoid leukemia produced by a virus extracted by Moloney(34,35} 
from sarcoma 37. Inoculation of the virus will induce a generalized 
0 
0 
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lymphocytic leukami& in essentially 100 per cent of weanling and adult 
BALB/c mioe Within 2.5 to 3.0 months. Intraperitoneal inoculation of 
& homogenate of spleen and lymph nodes of a leukemic mouse will induce 
a generalized lymphocytic neoplasm in 10 to 14 days36 • · 
2. Spindle-cell sarcoma induced in the golden h~star by intra-
-
muscular injection of methylcholanthrene by Handlers~ in 1960 and now 
in its 89th passage. 
o. Bacteriophage Ir!sates 
Standardized bacterial preparations designated as "Bacterial Antigen 
Ste.phage Lysate a (Staphylococcus aureus, Serologic Types I and I·n" 
were obtained from Delmont Laboratories, Swarthmore, Pennsylvania • 
. 
The lysates are prepared b,y the commercial laboratory by lysing 
Staphylococcus aureus Serologic Types I and III. 
The lysates contain heat-labile and h~at-ste.ble antigenic fr&ctions 
of Staphylococcus aureus with its extracellular and intracellular 
enzymes and the culture media ingredients (sodium chloride, beef 
heart infusion, Bacto-Tryptose). They are standardized on the basis 
' 
of bacterial cell content and phage activity. Each m. containas 
2 %'10~ '!. lysed Staphylococcus aureus 
~ l x~ 101~:l active Staphllooocous aureus 
bacte~iophage partie es. 
' 
In order to preserve maximum antigenic potency and phage activity 
no preservative is added. T-he lysates are tested prior to delivery 
for safety and sterility according to United States Public Health 
Service requirements for biologic products.~ 
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Experiment I -Viral Leukemia of the lJouse 
One of the 14 leukemic mice was killed and an, equal quantity of 
leukemic spleen and lymph node material removed. This was homogenized 
in an Elvejhem homogenizer and then diluted 1:1 with 0.9% NaCl. 
This mixture was injected intraperitoneally into 12 healthy mice. 
Six mice were given lysate Type III intraperitoneally 3 times per 
week. starting the day before the mice were inoculated with the leuk-
emic homogenate. Dosage of the lysate was started at l/8 co and 
increased by 1/B cc. until a dosage of 1/2 oo was reached. The dose 
was then maintained at the 1/2 co. level. The other 6 mice received 
intraperitoneal injections of 0.9% Nacl in the same dosage as the 
lysate. 
Of the remaining 13 leukemic mice, 7 reoeivea lysate Type lill 
3 times per week. the other 6 receiving injections of 0.9% NaCl. 
Experiment II - Transplanted Sarcoma of the Hamster 
The 60 golden hamsters were divided into 3 groups of 20 animals 
each. 
In the pilot studymore tumor regressions had been obtained using 
subcutaneous injection of the lysate than had occurred following' 
direct injection into the tumor. It was therefore decided that the 
subcutaneous route would be employed. By using this route a standard 
dose of 0.5 cc. per ingsotion could be maintained, while an intratumor 
16. 
dose would of necessity vary With the size of the tumor. Also the 
variable int~oduoed by m?ehanioal injection into the tumor would 
thereby·ba eliminated. 
Subcutaneous injections were made between the scapulae as follows~ 
Group A - Type I lysate 
Group B - Type IIr lysate 
Group C (control) - Sterile heart infusion b~oth 
This was done to insure presence of the lysates in the bodies of the 
animals before transplantation. 
Two days later another 0.5 co. of the respective mater~als was 
given to all the animals and 1 cu. mm • .t of the spindle cell sarcoma frO!l 
a single donor was transplanted to the right cheek pouch. 
The right Cheek pouo~ was everted with forceps, pinned out over 
a luoite block and swabbed with zephiran dilute.d 1:2000 with ma~lian 
ringer's solution. A 15-gauge trochar was loaded with a piece of tumor 
tissue 1 cu. mm. ±in size and inserted through the stratified 
squamous epithelium of the cheek pouch. A ~all pocket was made 
in the underlying fibrous connective tissue by manipulation of the 
trochar, the tumor tissue ejected into the pocket, and the trochar 
removed. The incision closed itself without suturing due to the 
contractility of the pouch. 
The animals were injected with lysate or broth and'the tumora 
observed and measured 3 times per week for 37 days. The first obser-
vation was made on the 4th day after transplantation. By this day 
most of the tumors had "taken" and were beginning to vascularize • 
. 
One control animal was found dead on this day., so was omitted from 
0 
the study~ making the total number of controls 19. The observations 
were made under a binocular dissecting microscope until such time as 
the tumors were large enough to make this unnecessaey. The animals 
were anesthetized with sodium pentabarbital (Nembutal, Abbott) injected 
: . 
intraperitoneally in dosages of 0.15 cc. per 100 grams body weight 
with fortification of 0.05 cc. when necessary. The majority of the 
tumors tended to be spherical. Their diameters were measured with a 
millimeter rule, each measurement being checked twice. It was felt 
that this''method would give as accurate comparative diameters as would 
the use of calipers. 
Mortality in the 3 groups was roughly the same: at the end of 
the study {37 days after transplantation) there were 16 animals in 
Group A, 13 in Group B and 15 controls remaining alive. 
During the study, tumors which regressed to near the vanishing 
point were excised, fixed in Zenker's fixative and prepared by the 
paraffin method for sectioning to dete~ine what cytological changes 
had occurred. Non-regreasing tumors were excised when central necrosis 
became too large to permit accurate measurement of the tumor mass. 
The viable sarcoma tissue around the periphery was fixed for section-
ing to compare with that of the regressing tumors.· 
F.notographa ware taken on days 6, 17 and ·32, of a. .. typic!i.l·~ control 
animal and of the experimental anima}. shOWing the minimum amount of 
tumor growth on those days (see Figures 2 through 8). 
0 
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Retransplantation Study 
The animals ~re permitted a week's rest after excision of their 
tumors, then lysate injections were resumed at 5-to 6-day in~ervals 
to keep the animals immunologically stimulated. Twelve days after 
completion of the 37-day observation period those animals still living 
were given a transplant of 1 cu. mm.± of sarcoma to the remaining 
left cheek poucht (11 animals in Group A, 11 in Group B and 8 in 
Group c.} 
The purpose of this second transplant was to determine: 
1. W.hether the first transplantation of tumor followed by 
regression and/or excision would render the animals resistant to 
further transplants. 
2. 'VIhether those animals who had been immunologically stimulated 
by the bacterial lysates would reject their transplants more frequently 
than the control group. 
No further doses of lysate "ere given after the second trans-
plantation was made. The animals ware observed at roughly weekly· 
interrals for 30 days. 
RESULTS 
0 
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III .Results 
A. Experinwnt r - Viral. Leukemia of the Mouse 
l... The mice which were already leukemic when received ware all 
dead within 26 days after arrival. ~he treated group.lived no longer 
than the controls. At autopsy the spleens and lymph nodes of the 
treated animals showed as great a degree of enlargement as did the 
controls. 
2'. The mice which were started on lysate therapy before the 
leUkemic homogenatos were injected were all dead of leukemia within 
33 days after injection. with the exception of 2 mice (one control 
' 
and 1 treated animal) who showed no sign of leukemia upon autopsy. 
The treated mice lived no longer than the controls, and 
the course of their disease appeared unaltered in any way by the 
lysate therapy. 
Since in both A and B above the death rates of treated and 
control groups were the same, the chi square value for the experiment 
would be zero. 
) 
Figure 1. Mouse with leukemia induced by 
injection of homogenate of infected 
spleen and lymph nodes. Note 
grossly enlarged spleen. 
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B. Experiment II - Transplanted Sarcoma. of the Hamster 
1. Comparison of Mean Diameters 
l 
A comparison of the mean diameters of the tumors (Table I) in 
the 3 groups showed the means of both Group A ( treate.d with lysate 
Type I) and group B (treated with lysate Type III) t~ be someWhat 
/ smaller than those of the controls through the 11th day after trans-
plantation. When standard deviations were calcula.ted<39 ), however. 
! 
the mean diameters of the treated groups all fell within one standard 
21. 
deviation of the control group values. Therefore the apparent differ-
ences between the means of the 3 groups were not siglificant. 
The mean diameters of the 3 groups were plotted lgainst time 
,I 
following transplantation (see graph Figure 9). The curves for the 
• 'I 
3 gr'oups showed an initial period of slow growth through day 7 • then 
I 
rapid growth from day 7 to day lB. By the 21st day the Group B means 
had stopped their steep rise and the curve began to fluctuate. Groups 
it 
A and C maintained rapid growth through day 23, then•began to taper 
off. All the groups reached maximum size by day 27, after which the 
means decreased. The decrease in size was due to the advanced necrosis 
and sloughing of tissue whiCh altered the spherical shape of the tumors 
and made accurate measurement impossible. The graph was not continued 
after the 30th day of the experiment. 
Since day 18 was the last day when measurements could be made 
with any degree of accuracy, and since all regressions which occurred 
did so within the first 11 days, the graph from day 1 to day 18 was 
enlarged and points plo~ted for the standard deviations of Groups A 
and c. As can be readily seen, the growth curves for all 3 groups 
fall within one standard deviation of the control group. (Figure 10). 
Figure 2. Tumor in cheek pouch of hamster treated with 
staphylococcus lysate, 6th day after trans-
plantation, diameter 2 Jllll• Enlargement 30X. 
Figure 3. Tumor in Cheek pouch of control animal, 6th 
day after transplantation, 3tmm. diameter. 
Enlargement 30X. 
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Figure 4. Cheek pouch of treated 
ani.nal 17 days after 
transplantation. No 
tumor in evidence. 
Enlargement 2X 
Figure 5. Detail of cheek pouch 
shown in Figure 3. 
Arrow indicates site 
where tumor had been 
implanted. Enlarge-
ment 30X. 
Figure 6. Tumor in cheek 
pouch ot con-
trol 17 days 
after trans-
plantation. 
( 
13 mm.. diame 
Enlargement 2L 
N 
CA 
• 
( 
• 
Figure 7. Tumor in oheek pouoh of treated 
ani.Dal 32 days atter transplantation. 
10 mm. diameter. Central necr~sis 
just beginning. Enlargement 2~ 
41 
Figure 8. Tumor in cheek pouch of control 
animal 32 days after trensplanta tion. 
21 mm. diameter. Necrotic process 
far advanced. Enlargement 2iJc. 
N 
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TABLE I 
Mean Diameters .t:t:n :mm.:~):·an:d Standatd'Jleviations 
GROUP A GROUP B GROUP C 
Day Mean Standard ilean s:Sandard )J~an Sianctard 
Deviation - Deviation Deviation 
4 1.97 0.68 2.1'7 0.62' 2.4 0.77 
77 2.47 0.98 2.55 0.72 2.73 0.91 
9 3.36 1.46 3.16 0.93 3.32 1.2 
11 4.33 1.5 4.0 1.2 4.57 1.4 
14: 7.48 2.0 6.2 1.46 6.63 1.71 
16 9.25 2.15 8.28 2.1 a.a 1.76 
18 11.8 2.7 11.0 • 10.8 1.98 
21 12.0 4.0 13.6 13.1 1.8 
23 13.2 
* 
17.5 16.0 *· 
26 14.9 19.1 17.3 
28 13.7 16.3 15.7 
30 14.,2 16.3 15.9 
33 1,.4 16.0 16.7 
37 15.5 17.3 18.6 
* After this point the variation in the tumors was so great that a 
negative standard deviation was obtained. 
Figure 9 ~ Mean Tumor Diameter Ov~r Period of 30 Days 
2~) 26. 
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2. Regressions 
rn Group A, 4 out of 20 tumors (20%) regress.ed. One tumor (5%) 
. . 
regressed in Group B, and 3 tumors showed retarded ~rowth. One tumor 
(5%) regressed in Group c, and 1 tumor showed retarded growth. 
In order to determine whether 4 regressions had any statistical 
significance, a chi square test was done of Groups A and C as follows: 
Tumors Tumors 
Growing Regressed Total 
Oontrola 18 (a) 1 (c) 19 (e) 
Group A 16 (b) 4 (d) 20 (£) 
._ 
Totals 34 <!li2 5 (h) 39 ~k2 
Observed Expected b. ~j.2 6..2/Expeoted 
18 {a) eg/k :: {19)(34)/39 = 16.55 1.45 2.1 0.127 
16 (b) fg/k = (20)(34)/39 • 17.42 1.42 2.0 0.115 
1 (c) eh/k = (19)(5 )/39 - 2.44 1.44 2.1 0.861 
4 (d) hfjk = ( 20 )( 5 )/39 - 2.56 1.44 2.1 0.837 
Chi square • • • • • • ••• • • • • • • • • • ••• • • • • • • 1.940 
A chi square of 1.94 indicates a probability of between 1Q% and 
25% that the difference between the two groups had occurred by chance. 
According to Snedeco~40), a chi square value ~ust be at least as 
large as 3.841 (indicating a probability of less than 5%) before the 
' 
difference between 2 groups oan be considered significant. 
3. Histological Study 
Regressing tumors •ere excised as they approached the macroscopic 
vanishing point so that the apparently absorbing tissue could be 
studied histologically. An equal number of rapidly growing tumors in 
the same group as the regressing tumors ware excised to ~erve aa 
histological control&. Three tumors in Group B and l in Group C 
Which were exhibiting markedly retarded growth curves were also ex-
cised and sectioned for study. They were fixed in Zenker's fixative 
and stained with hematoxylin and eosin. 
In general, the healthy control tumors in each group displayed 
cells with large, pale nuclei bearing one or more dark nucleoli. 
Mitotic cells were frequently seen, averaging 1.2 mitoses per field. 
(Oil immersion, 970X enlargement). Ten fields were counted for each 
tUmor. Same polymorphonuclear leukocyte& were present, averaging 
3.8 per field. Figure, ll is a photomicrogr~ph of a. typical section 
of a control tumor. Group C tumors did not differ appreciably from 
the treated groups. 
Th• regressing tumors showed shrunken, dark, stronglybasophilio 
nuclei in:which nucleoli were not &een. The nuclei were eccentric in 
shape and were more scattered than in the rapidly growing tumors. 
More fibrous connective tissue was present within these tumors. Polye 
morphonuclear leukocytes were numerous, averaging 14.5 pe~ field. 
Mitoses were rare, averaging 0.4 per field. One tumor displayed 
many'amitotic figures which were not counted as regular mitoses. 
Vascularization was poor or absent. Figure, 1~ is a'photomierograph 
of a typical section of a regressing tumor. • 
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Figure 11. Photomicrograph at typiea~ section ot a control tumor. 
Arrows indicate mitoses. Enlargement 430X. 
Figure 12. Detail of above, enlargement 900X. 
Figure 13. Photomicrograph of a typical seotion of a 
regressing tumor. Enlargement 43QX. 
Figure 14. Detail of above, enlargement 900X. 
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Figure 15. Polynuclear malignant cells in regressed 
tumor of control. Enlargement 430X. 
Figure 16. Detail of above, enlargement 900X. 
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TABLE II• HISTOLOGICAL S T U D Y s P 0 L Y M 0 R IP H 0 N U C L E A R LEUKOCYTES AND MITOSES 
GROUP A GROUP B GROUP c 
Regressed or Stationary Growing Regressed or Stationary Growing Regressed or Stationary 
I Da.y Polys Mitoses # Day Polys Mitoses 
' 
Day Polys Mitoses :fl= Day Polys Mitoses =fF Day Polys Mitoses =fF 
Excised per per Excised per per Excised per per Excised per per Excised per per 
field field field field field field field field field field 
12A 9 0 0 9A 21 8.2 0.9 7B 9 2.4 0 14B* 16 18.9 2.1 1C 9 26.0 0.6 2C• 
5A 12 10.2 0 13A 21 a.o 0 18B't 16 21.1 o.a 15B• I 16 0.3 0.7 150 
16A. 12 5.1 0.1 14A. 21 0 2.6 3B I 21 2.8 2.1 4C 
17.A 12 7.9 0.1 7A 37 2.9 1.6 13B I 21 2.0 1.0 l3C 
Total 23.2 0.8 13.1 5.1 23.5 o.a 24.0 5.9 26.0 0.6 
Average 5.8 0.2 3.3 1.3 11.7 0.4 6.0 1.5 26.0 o.s 
* Tumor had remained stationary 13 days before excision. 
* Tumor had shown markedly retarded growth before excision. 
I ) 
- ___ I ---
\ 
G.rowing 
Day Polys .DlitOI 
Excised per per 
field fielt 
11 4.0 0 
16 0 1.~ 
21 3.4 1.~ 
37 0.5 o.s 
1.9 3.2 
2.0 o.9 
0 
0 
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The one regression oceurriDg in the controls differed from those 
occurring in the treated groups in one respect. There were present 
in tumor lC a moderate number of hugh polynuclear malignant oells 
with up to 6 discrete dark nuclei. These cells were at least 3 times 
as large as the ordinary cancer cells (see Figure lt1i)• 
Table II summarizes the data fo~mitotic cel~s and polymorphonuclear 
leukocytes. 
4. Retransplantations 
Those animals which had received Type III lysate (Group B) had 
4 regressions out of 11 transplsnts •. Group A (Type I lysate)rhad 
-
one 11no take 11 out of 11 transplantations; that is, no sign of tumor 
~ 
tissue could be located 4 days after transplantation. Group C also 
had 1 "no take" out of 7 transplent~tions. 
~ ~ 
It is difficult to decide mather a "no take 11 should be considered 
. 
a regression or an error in transplantation, since no histological 
study was done on this part of the project. Assuming the no takes to 
be regressions, a chi square test was done as folloWs: 
Tumors Tumors 
Growing Regressed Total 
Controls 6 (a) 1 (c) · 7 (e) 
Group B 7 (b) 4 (d) 11 (f) 
Totals 13 (g) 5 (h) 18 (k) 
Observed Expected 2 ~/Expected, 
7 (a) eg;k = ( 7)(13 )/18 : 5.05 1.95 3.80 0.75 
13 ~b) fg/.k = (11)(13)/18= 7.94 5.06 25.60 3.23 1 eh/k = (7)(5)/18 = 0.67 0.33 0.11 0.16 
4 (~~ hf/k = (5)(11)/18 = 3.05 0.95 0.90 0.30 
Chi square • • • • • • • • • • • • •• • • • • • • • • • • • 4.44 
0 
0 
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A Chi square ~~~ue of 4.44 corresponds to a probability of less 
.5% that the 2 groups are the same. Therefore, it may be considered 
that the number of regressions obtained in Group B is statistically 
significant. 
0 
DISCUSSION AND 
CONCLUSIONS 
0 
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IV. Discussion and Conclusions 
A· Discussion 
It is well known that microorganisms synthesize an enor.mous range 
and variety of produota4l. Hany of these products cannot, in fact, 
be synthesized in any other manner e.t the present time. Aa a group, 
microorganisms produce enzymes which can digest almost any organic 
substance known42. A large portion of the drug industry today is 
concerned with locating microorganisms Which produca substances of 
antibiotic value4,42• 
· It does not se~ unreasonable, therefore, in the search for some 
means of controlling cancer, to investigate the products of microbial 
metabolism, many of 'Which are potent antigens, as well as the viruses 
Which are parasitic upon these microbes. Since precise knowledge 
regarding the cause of malignant growth is lacking, this sort of 
a.mpirical approaCh seems necessary. Many advances in medical science 
have been made through such an approach, such as the treatment of 
pernicious anemia With liver extracts~ of decompensated heart failures 
With digitalis and malaria therapy in general paresis. 
Reports of viruses being utilized to effect oncolysis have 
43 44 • 
occurred since 1912 ' , and this work has reoe1ved considerable 
impetus during the last decade. Moore45•46 lists 11 such viruses 
which have proved effective in destroying one or more types of 
tumor, at the expense, however, of also killing the host animal. The 
majority of these viruses have been neurotropic. Turner and Mulliken47 ' 48 
report prglongation of life in a si~~ifice.nt number of leukemic mice 
treated with vaccinia virus, and Noguchi !!!!•49 report the clearing 
0 
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up o£ skin cancer lesions with the Sal!le agent. Briody50 also used 
vaccinia virus to destroy EhrliCh acites carcinoma cells in the mouse. 
The mechanism for this tumor .. destroying effect is unknown~ but the 
investigators cited postulate that viral oncolysis maybe brought 
about through a met~bolic competition and/or antagonism. 
~th regard to the work of Christensen and Kjems, their results 
seem to indicate that some factor present in bacteriophage lysates 
o~ hemolytic streptococci is operating to retard or completely to 
inhibit malignant growth. (These experiments must, of course, be 
proved capable of duplication by other investigators before this 
can be accepted as more than a postulate.} Since there is no lmown 
specificity of bacterial viruses for mammalian cells, there is little 
reason to believe that the antitumor effect is brought about by the 
same mechanism as that operating with the animal viruses~ The 
authors themselves state, "we do not know whether the presence of 
. 
the phages is a presupposition for the tumor-inhibitory factor or 
whether they serve merely to release this factor from t~e bacteria 
in a gentle manner". A1:ry conclusion on this problem must, of course, 
await further data on the metabolism of both viruses and mammalian 
I 
cells. 
~re specific possible explanations for the effect of bacterial 
lysates upon tumors would seem to lie 
1. along the line suggested by Algire: that is, that 1the toxic 
constituents of the bacterial lysates may become localized in tumors 
and are capable of acting as selective vascular poisons without 
0 
f 
affecting nor.mal tisau~; or 
l 2. in the observa~ions of the many investigators cited in the 
I 
historical section of this thesis, e.g. Shear~2 ~ 23 an4 Jacobsen20 I . 
who feel that stimulatlon of the specific and/or non-specific immune 
mechanisms ~f tho an+ is involved. 
' 
In tha'experimentsliuvolving.hamstors treated with tho stapbylo• 
I 
coccus lysatea, two ofjthe Group A tumors had regressed to a micro-
! 
scopic level by the fo~th day. No blood vessels could be seen 
\ 
microscopically; but whether or not a hemorrhagic vascular reaction 
' I 
had occurred is not kn:own. Another regression showed no sign of 
hemorrhagic reaction. I The fourth regression was hemorrhagic on the 
fourth day, but so was one tumor in this group which continued to 
grow rapidly. In Group B the one tumor which regressed and on•· tumor 
which had remained stationary ~re hemorrhagic, but one tumor in 
this group which attained full size showed early he.morrhage. In 
control Group 0 the one regression was not hemorrhagic, but one 
tumor which grew normally was. It would appear, therefore, that 
there was no particular correlation between regression and hemorr• 
hagio reaction in these animals. 
~ith a transplanted tumor, of course, it is extremely difficult 
to determine ~ether regressions of the tumor is due to a specific 
host reaction against the tumor cells or merely a generalized reao• 
tion against the implantation of foreign tissue. In further studies~ 
contro~ ~an~pla.nts of normal connective tissue from the tumorous 
hamster used as donor would be instructive. 
38. 
39. 
In §-roup A (animals treated with lysate Type I) 20% of the tumors 
. .. 
regressed as compared ~th the controls, 5% oe Which regressed. The 
statistical analysis of these regressions indicates a rather large 
probability (between 10 and 25%) that the apparent difference bet¥reen 
the 2 groups occurred by chance. Further studies employing a larger 
number of animals would be necessary in order to deter.mine whether the 
Type I lysate was actually instrumental in causing regression of the 
treated ttunors. 
In any event, in evaluating this study, several points should be 
lield in mindJ 
1. Different types of malignancy frequently react to a given 
therapeutic preparation in different ways. Only two types of neo-
plasm were used in this experiment. The next logiqql step wo~ld 
be to treat a whole spectrum of tumors, both spontaneous and induced, 
to determine what range of effects the lysates might have. 
2. Experimental animals vary from species to species in their 
response to certain treatments. Clearly the leukemic mice showed 
~o detected response to lysate therapy. No regressions or apparent 
r-emissions occurred, and· chi square for the treated vs. the control 
groups was equal to zero. The hEIIllSters, however, showed a difference 
in response between treated and control groups which gave a chi square 
of 1.94 which indicates a probability level of between lo% and 25%. The 
possibility that other species of animal might respond to lysate 
therapy should therefore not be ruled out. 
3. Only one dosage was used in the hamster, and one route of 
inoculation. Varied dosages and such routes as the intravenous and 
intraperitoneal should also be investigated. 
4. T.here are a very large number of strains of h~olytic staphy-
lococcus~ many of mich carry a phage which is capable of lysing 
them. The two strains used in these experiments may not be the 
strains best suited to the initiation of tumor destruction. The 
two phages used in these experiments apparently varied between them-
selves in their effect an the animals. T.he group treated with Type I 
lysate had more regressions than the, group treated With Type III; 
yet the' animals treated with type III were apparently more able to 
reject a second transplant. 
The small number of animals remaining alive for the retransplant-
ation part of the study prohibits any definite conclusion to be 
. 
drawn. It is suggestive, however, that the Type III lysate in some 
manner stimulated the immune mechanism of these antmals. 
Pelner24 states "There is considerable evidence to ingicate that 
. 
the ability of an animal or patient to elicit an acute intlamma• 
tory reaction is one of the powerful inhibitors to successful trans-
plantation of tumors or to the formation of metastaaes 11 • 
~ 
In future work the tumors should be viewed perhaps twice daily 
following transplantation in order to observe any inflammator,y or 
hemorrhagic reactions, which may occur. 
The histological stuqy of the regressing tumors was useful in 
ascertaining Whether a pouch in which no tumor was evident on day 4 
was a rejection of the tumor by the host or a transplantation error. 
Apparently no transplantation errors occurred in the main experiment, 
as regressing tumor cells were located in sections of both pouches 
which were questionable. 
40. 
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B. Conclusions 
I 
1. The treatment of BALB/c leukemic ndce with the particular 
staphylococcus ba.ct.eriophage lysates used, at the dosage specified, 
was totally ineffective. 
2. Treatment of hamsters bearing transplanted spindle cell 
sarcoma. with the particular staphylococcus lysates used, at the 
dosage specified, does not result in a dramatic number of tumor 
regressions as compared with untreated controls. However, further 
research along this line does appear justified. 
3. There is some evidence that animals treated with lysate 
Typo III during the development of a transplanted sarcoma will, 
after the sarcoma has been excised, be resistant to a second trans-
plantation of the sarcoma. Untreated controls were not resistant to 
the second transplantation. 
0 
